Monday, October 10, 2011
Wednesday, September 21, 2011
2011 conference
Just back from conference 2011 held at goa.
Its was vey sad to know that one of the society is over powered by the company. Some speaker were so biased that they would rather deviate from gold standard treatment and engurage new brains to buy new technology. Even expensive and dont stand on the standard!!!!
Its was vey sad to know that one of the society is over powered by the company. Some speaker were so biased that they would rather deviate from gold standard treatment and engurage new brains to buy new technology. Even expensive and dont stand on the standard!!!!
Sunday, September 11, 2011
History of Lithotripsy!!
The first reports on the fragmentation of human calculi with ultrasound appeared in the fifties. Initial positive results with an extracorporeal approach with continuous wave ultrasound could, however, not be reproduced. A more promising result was found by generating the acoustic energy either in pulsed or continuous form directly at the stone surface. The method was applied clinically with success. Extracorporeal shock-wave generators unite the principle of using single ultrasonic pulses with the principle of generating the acoustic energy outside the body and focusing it through the skin and body wall onto the stone. Häusler and Kiefer reported the first successful contact-free kidney stone destruction by shock waves. They had put the stone in a water filled cylinder and generated a shock wave with a high speed water drop which was fired onto the water surface. To apply the new principle in medicine, both Häusler and Hoff's group at Dornier company constructed different shock wave generators for the stone destruction; the former used a torus-shaped reflector around an explosion wire, the latter the electrode-ellipsoid system. The former required open surgery to access the kidney stone, the latter did not. It was introduced into clinical practice after a series of experiments in Munich.
Saturday, August 13, 2011
How to choose lithotripsy unit ?

2. What is the peak pressure at the focal zone?
3. Is the energy delivery at focal zone consistent?
4. Is the energy delivered at focal zone adequate (not more than required for stone fragmentation)?
5. Do I have enough control over the energy delivered manually?
6. Do I have enough steps of increasing energy before I reach desired energy level?
7. Does every patient require anesthesia for lithotripsy?
8. Do I have dynamic monitoring of stone during lithotripsy?
Try to grade lithotripsy unit in following category.
| Properties of lithotripsy | | Machine A | Machine B | Machine C |
| Focal zone | Larger the better | | | |
| Energy delivery at focal zone | | | | |
| Is the energy at focal zone constant | | | | |
| Control over the energy delivered manually | Does machine have manual selection of energy | | | |
| Steps of increasing energy before you reach desired energy level | More the steps better | | | |
| Patient require anesthesia (GA/SA) | Ideally no anesthesia or only analgesia should be required | | | |
| Dynamic monitoring -USG | USG is better for Lithotripsy | | | |
| Total score | | | | |
Saturday, May 7, 2011
Heel pain and ESWT
15 % of adults compain of heel pain
1 out of 8 patient visiting orthopedicean has heel pain
1/4 of all foot injury and 8% of overall injuries to runner and other athletes is heel pain
Only option available is Local steroid
But with now ESWT the results are amazing
Today ESWT is standard treatment for Plantar fasciatis
1 out of 8 patient visiting orthopedicean has heel pain
1/4 of all foot injury and 8% of overall injuries to runner and other athletes is heel pain
Only option available is Local steroid
But with now ESWT the results are amazing
Today ESWT is standard treatment for Plantar fasciatis
Saturday, April 16, 2011
ESWT for Diabetic foot ulcer
Background: Diabetes is becoming one of the most common chronic diseases, and ulcers are its most serious complication. Beginning with neuropathy, the subsequent foot wounds frequently lead to lower extremity amputation, even in the absence of critical limb ischemia. In recent years, some researchers have studied external shock wave therapy (ESWT) as a new approach to soft tissue wound healing. The rationale of this study was to evaluate if ESWT is effective in the management of neuropathic diabetic foot ulcers.
Methods: We designed a randomized, prospective, controlled study in which we recruited 30 patients affected by neuropathic diabetic foot ulcers and then divided them into two groups based on different management strategies. One group was treated with standard care and shock wave therapy. The other group was treated with only standard care. The healing of the ulcers was evaluated over 20 weeks by the rate of re-epithelization.
Results: After 20 weeks of treatment, 53.33% of the ESWT-treated patients had complete wound closure compared with 33.33% of the control patients, and the healing times were 60.8 and 82.2 days, respectively (p < 0.001). Significant differences in the index of the re-epithelization were observed between the two groups, with values of 2.97 mm2/die in the ESWT-group and 1.30 mm2/die in the control group (p < 0.001).
Conclusion: Therefore, ESWT may be a useful adjunct in the management of diabetic foot ulceration.
Methods: We designed a randomized, prospective, controlled study in which we recruited 30 patients affected by neuropathic diabetic foot ulcers and then divided them into two groups based on different management strategies. One group was treated with standard care and shock wave therapy. The other group was treated with only standard care. The healing of the ulcers was evaluated over 20 weeks by the rate of re-epithelization.
Results: After 20 weeks of treatment, 53.33% of the ESWT-treated patients had complete wound closure compared with 33.33% of the control patients, and the healing times were 60.8 and 82.2 days, respectively (p < 0.001). Significant differences in the index of the re-epithelization were observed between the two groups, with values of 2.97 mm2/die in the ESWT-group and 1.30 mm2/die in the control group (p < 0.001).
Conclusion: Therefore, ESWT may be a useful adjunct in the management of diabetic foot ulceration.
Friday, April 8, 2011
Subscribe to:
Posts (Atom)